Skip to main content
PMC home page
RNA logoLink to RNA
. 1999 Aug;5(8):1071–1082. doi: 10.1017/s1355838299981803

Finding the right RNA: identification of cellular mRNA substrates for RNA-binding proteins.

P Trifillis 1, N Day 1, M Kiledjian 1
PMCID: PMC1369830  PMID: 10445881

Abstract

Defects in RNA-binding proteins have been implicated in human genetic disorders. However, efforts in understanding the functions of these proteins have been hampered by the inability to obtain their mRNA substrates. To identify cognate cellular mRNAs associated with an RNA-binding protein, we devised a strategy termed isolation of specific nucleic acids associated with proteins (SNAAP). The SNAAP technique allows isolation and subsequent identification of these mRNAs. To assess the validity of this approach, we utilized cellular mRNA and protein from K562 cells and alphaCP1, a protein implicated in a-globin mRNA stability, as a model system. Immobilization of an RNA-binding protein with the glutathione-S-transferase (GST) domain enables isolation of mRNA within an mRNP context and the identity of the bound mRNAs is determined by the differential display assay. The specificity of protein-RNA interactions was considerably enhanced when the interactions were carried out in the presence of cellular extract rather than purified components. Two of the mRNAs specifically bound by alphaCP1 were mRNAs encoding the transmembrane receptor protein, TAPA-1, and the mitochondrial cytochrome c oxidase subunit II enzyme, coxII. A specific poly(C)-sensitive complex formed on the TAPA-1 and coxII 3' UTRs consistent with the binding of aCP1. Furthermore, direct binding of purified alphaCP proteins to these 3' UTRs was demonstrated and the binding sites determined. These results support the feasibility of the SNAAP technique and suggest a broad applicability for the approach in identifying mRNA targets for clinically relevant RNA-binding proteins that will provide insights into their possible functions.

Full Text

The Full Text of this article is available as a PDF (630.2 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Aasheim H. C., Loukianova T., Deggerdal A., Smeland E. B. Tissue specific expression and cDNA structure of a human transcript encoding a nucleic acid binding [oligo(dC)] protein related to the pre-mRNA binding protein K. Nucleic Acids Res. 1994 Mar 25;22(6):959–964. doi: 10.1093/nar/22.6.959. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Attardi G., Chomyn A., Montoya J., Ojala D. Identification and mapping of human mitochondrial genes. Cytogenet Cell Genet. 1982;32(1-4):85–98. doi: 10.1159/000131689. [DOI] [PubMed] [Google Scholar]
  3. Blyn L. B., Towner J. S., Semler B. L., Ehrenfeld E. Requirement of poly(rC) binding protein 2 for translation of poliovirus RNA. J Virol. 1997 Aug;71(8):6243–6246. doi: 10.1128/jvi.71.8.6243-6246.1997. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Buckanovich R. J., Yang Y. Y., Darnell R. B. The onconeural antigen Nova-1 is a neuron-specific RNA-binding protein, the activity of which is inhibited by paraneoplastic antibodies. J Neurosci. 1996 Feb 1;16(3):1114–1122. doi: 10.1523/JNEUROSCI.16-03-01114.1996. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Engel P., Tedder T. F. New CD from the B cell section of the Fifth International Workshop on Human Leukocyte Differentiation Antigens. Leuk Lymphoma. 1994;13 (Suppl 1):61–64. doi: 10.3109/10428199409052677. [DOI] [PubMed] [Google Scholar]
  6. Gamarnik A. V., Andino R. Two functional complexes formed by KH domain containing proteins with the 5' noncoding region of poliovirus RNA. RNA. 1997 Aug;3(8):882–892. [PMC free article] [PubMed] [Google Scholar]
  7. Hargrove J. L., Schmidt F. H. The role of mRNA and protein stability in gene expression. FASEB J. 1989 Oct;3(12):2360–2370. doi: 10.1096/fasebj.3.12.2676679. [DOI] [PubMed] [Google Scholar]
  8. Holcik M., Liebhaber S. A. Four highly stable eukaryotic mRNAs assemble 3' untranslated region RNA-protein complexes sharing cis and trans components. Proc Natl Acad Sci U S A. 1997 Mar 18;94(6):2410–2414. doi: 10.1073/pnas.94.6.2410. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Kiledjian M., Day N., Trifillis P. Purification and RNA binding properties of the polycytidylate-binding proteins alphaCP1 and alphaCP2. Methods. 1999 Jan;17(1):84–91. doi: 10.1006/meth.1998.0710. [DOI] [PubMed] [Google Scholar]
  10. Kiledjian M., DeMaria C. T., Brewer G., Novick K. Identification of AUF1 (heterogeneous nuclear ribonucleoprotein D) as a component of the alpha-globin mRNA stability complex. Mol Cell Biol. 1997 Aug;17(8):4870–4876. doi: 10.1128/mcb.17.8.4870. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Kiledjian M., Dreyfuss G. Primary structure and binding activity of the hnRNP U protein: binding RNA through RGG box. EMBO J. 1992 Jul;11(7):2655–2664. doi: 10.1002/j.1460-2075.1992.tb05331.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Kiledjian M., Wang X., Liebhaber S. A. Identification of two KH domain proteins in the alpha-globin mRNP stability complex. EMBO J. 1995 Sep 1;14(17):4357–4364. doi: 10.1002/j.1460-2075.1995.tb00110.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Leffers H., Dejgaard K., Celis J. E. Characterisation of two major cellular poly(rC)-binding human proteins, each containing three K-homologous (KH) domains. Eur J Biochem. 1995 Jun 1;230(2):447–453. [PubMed] [Google Scholar]
  14. Levine T. D., Gao F., King P. H., Andrews L. G., Keene J. D. Hel-N1: an autoimmune RNA-binding protein with specificity for 3' uridylate-rich untranslated regions of growth factor mRNAs. Mol Cell Biol. 1993 Jun;13(6):3494–3504. doi: 10.1128/mcb.13.6.3494. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Liang P., Bauer D., Averboukh L., Warthoe P., Rohrwild M., Muller H., Strauss M., Pardee A. B. Analysis of altered gene expression by differential display. Methods Enzymol. 1995;254:304–321. doi: 10.1016/0076-6879(95)54022-9. [DOI] [PubMed] [Google Scholar]
  16. Liang P., Pardee A. B. Differential display of eukaryotic messenger RNA by means of the polymerase chain reaction. Science. 1992 Aug 14;257(5072):967–971. doi: 10.1126/science.1354393. [DOI] [PubMed] [Google Scholar]
  17. Ma K., Inglis J. D., Sharkey A., Bickmore W. A., Hill R. E., Prosser E. J., Speed R. M., Thomson E. J., Jobling M., Taylor K. A Y chromosome gene family with RNA-binding protein homology: candidates for the azoospermia factor AZF controlling human spermatogenesis. Cell. 1993 Dec 31;75(7):1287–1295. doi: 10.1016/0092-8674(93)90616-x. [DOI] [PubMed] [Google Scholar]
  18. Maecker H. T., Do M. S., Levy S. CD81 on B cells promotes interleukin 4 secretion and antibody production during T helper type 2 immune responses. Proc Natl Acad Sci U S A. 1998 Mar 3;95(5):2458–2462. doi: 10.1073/pnas.95.5.2458. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Maecker H. T., Levy S. Normal lymphocyte development but delayed humoral immune response in CD81-null mice. J Exp Med. 1997 Apr 21;185(8):1505–1510. doi: 10.1084/jem.185.8.1505. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Miyazaki T., Müller U., Campbell K. S. Normal development but differentially altered proliferative responses of lymphocytes in mice lacking CD81. EMBO J. 1997 Jul 16;16(14):4217–4225. doi: 10.1093/emboj/16.14.4217. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Müeller-Pillasch F., Lacher U., Wallrapp C., Micha A., Zimmerhackl F., Hameister H., Varga G., Friess H., Büchler M., Beger H. G. Cloning of a gene highly overexpressed in cancer coding for a novel KH-domain containing protein. Oncogene. 1997 Jun 5;14(22):2729–2733. doi: 10.1038/sj.onc.1201110. [DOI] [PubMed] [Google Scholar]
  22. Oren R., Takahashi S., Doss C., Levy R., Levy S. TAPA-1, the target of an antiproliferative antibody, defines a new family of transmembrane proteins. Mol Cell Biol. 1990 Aug;10(8):4007–4015. doi: 10.1128/mcb.10.8.4007. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Ostareck D. H., Ostareck-Lederer A., Wilm M., Thiele B. J., Mann M., Hentze M. W. mRNA silencing in erythroid differentiation: hnRNP K and hnRNP E1 regulate 15-lipoxygenase translation from the 3' end. Cell. 1997 May 16;89(4):597–606. doi: 10.1016/s0092-8674(00)80241-x. [DOI] [PubMed] [Google Scholar]
  24. Ruff P., Speicher D. W., Husain-Chishti A. Molecular identification of a major palmitoylated erythrocyte membrane protein containing the src homology 3 motif. Proc Natl Acad Sci U S A. 1991 Aug 1;88(15):6595–6599. doi: 10.1073/pnas.88.15.6595. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Shay J. W., Werbin H. New evidence for the insertion of mitochondrial DNA into the human genome: significance for cancer and aging. Mutat Res. 1992 Sep;275(3-6):227–235. doi: 10.1016/0921-8734(92)90026-l. [DOI] [PubMed] [Google Scholar]
  26. Siomi M. C., Zhang Y., Siomi H., Dreyfuss G. Specific sequences in the fragile X syndrome protein FMR1 and the FXR proteins mediate their binding to 60S ribosomal subunits and the interactions among them. Mol Cell Biol. 1996 Jul;16(7):3825–3832. doi: 10.1128/mcb.16.7.3825. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Tedder T. F., Inaoki M., Sato S. The CD19-CD21 complex regulates signal transduction thresholds governing humoral immunity and autoimmunity. Immunity. 1997 Feb;6(2):107–118. doi: 10.1016/s1074-7613(00)80418-5. [DOI] [PubMed] [Google Scholar]
  28. Timchenko L. T., Timchenko N. A., Caskey C. T., Roberts R. Novel proteins with binding specificity for DNA CTG repeats and RNA CUG repeats: implications for myotonic dystrophy. Hum Mol Genet. 1996 Jan;5(1):115–121. doi: 10.1093/hmg/5.1.115. [DOI] [PubMed] [Google Scholar]
  29. Tommerup N., Leffers H. Assignment of human KH-box-containing genes by in situ hybridization: HNRNPK maps to 9q21.32-q21.33, PCBP1 to 2p12-p13, and PCBP2 to 12q13.12-q13.13, distal to FRA12A. Genomics. 1996 Mar 1;32(2):297–298. doi: 10.1006/geno.1996.0121. [DOI] [PubMed] [Google Scholar]
  30. Tsitsikov E. N., Gutierrez-Ramos J. C., Geha R. S. Impaired CD19 expression and signaling, enhanced antibody response to type II T independent antigen and reduction of B-1 cells in CD81-deficient mice. Proc Natl Acad Sci U S A. 1997 Sep 30;94(20):10844–10849. doi: 10.1073/pnas.94.20.10844. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Tuerk C., Gold L. Systematic evolution of ligands by exponential enrichment: RNA ligands to bacteriophage T4 DNA polymerase. Science. 1990 Aug 3;249(4968):505–510. doi: 10.1126/science.2200121. [DOI] [PubMed] [Google Scholar]
  32. Wang X., Kiledjian M., Weiss I. M., Liebhaber S. A. Detection and characterization of a 3' untranslated region ribonucleoprotein complex associated with human alpha-globin mRNA stability. Mol Cell Biol. 1995 Mar;15(3):1769–1777. doi: 10.1128/mcb.15.3.1769. [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. Wang Z., Day N., Trifillis P., Kiledjian M. An mRNA stability complex functions with poly(A)-binding protein to stabilize mRNA in vitro. Mol Cell Biol. 1999 Jul;19(7):4552–4560. doi: 10.1128/mcb.19.7.4552. [DOI] [PMC free article] [PubMed] [Google Scholar]
  34. Weiss I. M., Liebhaber S. A. Erythroid cell-specific determinants of alpha-globin mRNA stability. Mol Cell Biol. 1994 Dec;14(12):8123–8132. doi: 10.1128/mcb.14.12.8123. [DOI] [PMC free article] [PubMed] [Google Scholar]
  35. Weiss I. M., Liebhaber S. A. Erythroid cell-specific mRNA stability elements in the alpha 2-globin 3' nontranslated region. Mol Cell Biol. 1995 May;15(5):2457–2465. doi: 10.1128/mcb.15.5.2457. [DOI] [PMC free article] [PubMed] [Google Scholar]
  36. Wright M. D., Tomlinson M. G. The ins and outs of the transmembrane 4 superfamily. Immunol Today. 1994 Dec;15(12):588–594. doi: 10.1016/0167-5699(94)90222-4. [DOI] [PubMed] [Google Scholar]

Articles from RNA are provided here courtesy of The RNA Society

RESOURCES